ATE412738T1 - Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen - Google Patents

Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen

Info

Publication number
ATE412738T1
ATE412738T1 AT00420113T AT00420113T ATE412738T1 AT E412738 T1 ATE412738 T1 AT E412738T1 AT 00420113 T AT00420113 T AT 00420113T AT 00420113 T AT00420113 T AT 00420113T AT E412738 T1 ATE412738 T1 AT E412738T1
Authority
AT
Austria
Prior art keywords
strains
denguevirus
attenuate
vaccine compositions
serotype
Prior art date
Application number
AT00420113T
Other languages
English (en)
Inventor
Nath Bhamarapravat
Sutee Yoksan
Original Assignee
Univ Mahidol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mahidol filed Critical Univ Mahidol
Application granted granted Critical
Publication of ATE412738T1 publication Critical patent/ATE412738T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00420113T 2000-05-30 2000-05-30 Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen ATE412738T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00420113A EP1159968B1 (de) 2000-05-30 2000-05-30 Attenuierte Stammen von Denguevirus und ihre Verwendungen in Impfstoffzusammensetzungen

Publications (1)

Publication Number Publication Date
ATE412738T1 true ATE412738T1 (de) 2008-11-15

Family

ID=8174060

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00420113T ATE412738T1 (de) 2000-05-30 2000-05-30 Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen

Country Status (7)

Country Link
EP (1) EP1159968B1 (de)
AT (1) ATE412738T1 (de)
CY (1) CY1108666T1 (de)
DE (1) DE60040652D1 (de)
DK (1) DK1159968T3 (de)
ES (1) ES2315221T3 (de)
PT (1) PT1159968E (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101238144B (zh) 2005-06-17 2012-09-05 赛诺菲巴斯德有限公司 登革血清型1减毒株
CN101238209B (zh) 2005-06-17 2013-02-13 赛诺菲巴斯德有限公司 登革血清型2减毒株
US7968102B2 (en) 2006-01-13 2011-06-28 Sanofi Pasteur S.A. Dengue chimeric viruses
AR061197A1 (es) * 2006-06-07 2008-08-13 Sanofi Pasteur Cepas del virus 3 del dengue vivas atenuadas
FR2903605A1 (fr) 2006-07-12 2008-01-18 Sanofi Pasteur Sa Methode d'immunisation contre les quatres serotypes de la dengue
FR2906724B1 (fr) * 2006-10-04 2009-03-20 Sanofi Pasteur Sa Methode d'immunisation contre les 4 serotypes de la dengue.
FR2909286B1 (fr) * 2006-12-01 2012-06-08 Sanofi Pasteur Methode d'immunisation contre les 4 serotypes de la dengue
EP2589392B1 (de) 2008-03-05 2016-11-30 Sanofi Pasteur Stabilisierungsverfahren für eine adjuvanshaltige Impfstoffzusammensetzung
EP2143440A1 (de) 2008-07-09 2010-01-13 Sanofi Pasteur Stabilisierungssubstanz und Impfzusammensetzung, die ein oder mehrere abgeschwächte lebende Flaviviridae enthält
EP2353609A1 (de) 2010-02-04 2011-08-10 Sanofi Pasteur Immunisierungszusammensetzungen und -verfahren
JP2015524421A (ja) 2012-07-24 2015-08-24 サノフィ・パスツールＳａｎｏｆｉｐａｓｔｅｕｒ ワクチン組成物
SG11201500439RA (en) 2012-07-24 2015-02-27 Sanofi Pasteur Vaccine compositions for prevention against dengue virus infection
WO2014083194A1 (en) 2012-11-30 2014-06-05 Sanofi Pasteur Methods for inducing antibodies
CA3177574A1 (en) * 2013-03-15 2014-09-25 Takeda Vaccines, Inc. Compositions and methods for dengue virus chimeric constructs in vaccines
KR102297300B1 (ko) * 2015-11-27 2021-09-02 케이엠 바이올로직스 가부시키가이샤 뎅기 바이러스 약독주를 뱅크화한 생바이러스, 및 그것들을 항원으로 하는 뎅기 백신
BE1024160B9 (fr) 2015-12-22 2017-12-06 Glaxosmithkline Biologicals Sa Formulation immunogène
JP7313345B2 (ja) 2017-10-05 2023-07-24 サノフィ・パスツール デング熱に対するブースターワクチン接種のための組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6093296A (en) * 1995-06-07 1996-12-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Infectious dengue 2 virus pdk-53 as quadravalent vaccine

Also Published As

Publication number Publication date
PT1159968E (pt) 2008-11-20
EP1159968B1 (de) 2008-10-29
EP1159968A1 (de) 2001-12-05
DK1159968T3 (da) 2009-02-23
CY1108666T1 (el) 2014-04-09
ES2315221T3 (es) 2009-04-01
DE60040652D1 (de) 2008-12-11

Similar Documents

Publication Publication Date Title
CY1108666T1 (el) Εξασθενημενα στελεχη του δαγγειου πυρετου και η χρηση τους σε μια συνθεση εμβολιου
EA200300023A1 (ru) 3'-ПРОЛЕКАРСТВА 2'-ДЕЗОКСИ-β-L-НУКЛЕОЗИДОВ
DE60130987D1 (de) Assemblierung von wildtyp und chimären influenzavirus-ähnlichen partikeln (vlps)
DE60009511D1 (de) Nematizide trifluorbutene
DE69031560D1 (de) Verfahren und zusammensetzungen zum stimulieren von vesikulär-arbuskulären mykorrhizapilzen
RS100504A (en) Hepatitis c virus inhibitors
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
NO20026044D0 (no) Behandling av human papillomavirus
NO955047L (no) Sekundære aminer som antidiabetiske og antifedme-midler
DE69232665D1 (de) Neue 4-arylpiperazine und 4-arylpiperidine
NO20004978D0 (no) Semi-syntetiske ecteinascidiner
ATE333500T1 (de) Virus des porzinen reproduktiven und respiratorischen syndroms und dessen verwendung
NO980848D0 (no) Piperazinoderivater som neurokininantagonister
WO2001007027A3 (en) Pyrimidine derivatives for the treatment of viral diseases
ATE205881T1 (de) Pharmazeutische zusammensetzung gegen durch papillomaviren verursachte tumoren und infektionen
TR200102120T2 (tr) 3-(2,4,6-trimetilfenil)-4-neopentilkarboniloksi-5, 5-tetrametilen-delta3-dihidrofuran-2-on'un beyaz sineği kontrol etmek için kullanımı.
ATE255105T1 (de) Serotonerge benzofurane
ATE223893T1 (de) Naphthopyranderivate, zubereitungen und dieselben enthaltende (co)polymermatrizen
DE69928646D1 (de) Derivate des streptogramins, ihre herstellung und sie enthaltende zubereitungen
DK0660822T3 (da) Cykliske benzylamino-, benzylamido- og benzylimidoderivater som antipsykotiske midler
ATE109139T1 (de) Mittel zum schutz von pflanzen gegen krankheiten.
ATE235450T1 (de) 2-indanmethanolderivate und ihre verwendung als riechstoffe
DK0937057T3 (da) Hidtil ukendte (-)-enantiomerer af cis-3,4-chromanderivater anvendelige i forebyggelse eller behandling af østrogenrelaterede sygdomme eller syndromer
ATE322541T1 (de) Pestivirus mutanten und dessen enthaltende impfstoffe
DE50001075D1 (de) 4-Alkanoyl-3-thiazoline und deren Verwendung als Riech- und Aromastoffe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1159968

Country of ref document: EP